Meeting Coverage
ASTRO
American Society for Radiation Oncology
Latest ASTRO Meeting Coverage
Detectable circulating tumor DNA before radiotherapy linked with worse survival
Time to treatment completion slashed by over 4 hours compared with CT simulation planning
Randomized trial a "game changer" for patients who have implant-based reconstruction, expert says
Treatment over 1 to 2 weeks achieves similar outcomes to therapy given for as long as 7.5 weeks
Intercourse and/or vaginal dilation reduces risk of vaginal stenosis
Phase II study shows 100% local control and cancer-specific survival after more than 3 years
Radiotherapy led to "dramatic" slowing of progression, increased time with normal testosterone
SMART safe in patients with borderline or locally advanced cancer, with encouraging early OS data
Reduces treatment time, noninferior to conventional RT with sequential boost after lumpectomy
Fewer skeletal events, less pain unexpectedly followed by longer life
Much less likely than men to be queried about sexual function when receiving treatment
Hypofractionation matches standard RT for survival and toxicity in a third less time
Will USPSTF's 2018 guidelines reverse this trend?
Stereotactic body radiotherapy plus sorafenib improves survival versus targeted drug alone
Latest Oncology/Hematology Meeting Coverage
-
ASTRO: American Society for Radiation Oncology
September 2024
-
ESMO: European Society for Medical Oncology
September 2024
-
ASCO: American Society of Clinical Oncology
May 2024
-
AACR: American Association for Cancer Research
April 2024